hydralazine has been researched along with Marfan Syndrome, Type I in 4 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Marfan syndrome is an inheritable connective tissue disorder with multisystem involvement and variable expression of signs and symptoms, caused by mutations within the fibrillin gene on chromosome 15q21." | 2.43 | Pregnancy in Marfan syndrome after aortic root replacement: a case report and review of the literature. ( Elami, A; Ezra, Y; Gilon, D; Ginosar, Y; Pollak, A; Volach, V, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habashi, JP | 2 |
| MacFarlane, EG | 1 |
| Bagirzadeh, R | 1 |
| Bowen, C | 1 |
| Huso, N | 2 |
| Chen, Y | 1 |
| Bedja, D | 2 |
| Creamer, TJ | 1 |
| Rykiel, G | 1 |
| Manning, M | 1 |
| Huso, D | 2 |
| Dietz, HC | 2 |
| Doyle, JJ | 1 |
| Doyle, AJ | 1 |
| Wilson, NK | 1 |
| Whitworth, RE | 1 |
| Lindsay, ME | 1 |
| Schoenhoff, F | 1 |
| Myers, L | 1 |
| Bachir, S | 1 |
| Squires, O | 1 |
| Rusholme, B | 1 |
| Ehsan, H | 1 |
| Thomas, CJ | 1 |
| Caulfield, MJ | 1 |
| Van Eyk, JE | 1 |
| Judge, DP | 1 |
| Volach, V | 1 |
| Elami, A | 1 |
| Gilon, D | 1 |
| Pollak, A | 1 |
| Ginosar, Y | 1 |
| Ezra, Y | 1 |
| Gallop, PM | 1 |
| Paz, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions[NCT01322165] | 3,706 participants (Actual) | Observational | 2007-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for hydralazine and Marfan Syndrome, Type I
| Article | Year |
|---|---|
Pregnancy in Marfan syndrome after aortic root replacement: a case report and review of the literature.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Aortic Diseases; Aortic Dissection; Blo | 2006 |
Posttranslational protein modifications, with special attention to collagen and elastin.
Topics: Amino Acid Sequence; Animals; Antibody Specificity; Ascorbic Acid; Collagen; Connective Tissue; Copp | 1975 |
2 other studies available for hydralazine and Marfan Syndrome, Type I
| Article | Year |
|---|---|
Oxytocin antagonism prevents pregnancy-associated aortic dissection in a mouse model of Marfan syndrome.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Aortic Dissection; Disease Models, Animal; Female; Hydr | 2019 |
A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome.
Topics: Adult; Animals; Antihypertensive Agents; Calcium Channel Blockers; Child; Child, Preschool; Disease | 2015 |